Sundaram Senthil Vel 4
4 · Terns Pharmaceuticals, Inc. · Filed Jan 28, 2022
Insider Transaction Report
Form 4
Sundaram Senthil Vel
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-26+280,000→ 280,000 totalExercise: $5.36Exp: 2032-01-26→ Common Stock (280,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.